Nonclinical Assessment of Abuse Potential for New Pharmaceuticals

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Reference & Language, Law, International
Cover of the book Nonclinical Assessment of Abuse Potential for New Pharmaceuticals by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780124202160
Publisher: Elsevier Science Publication: July 14, 2015
Imprint: Academic Press Language: English
Author:
ISBN: 9780124202160
Publisher: Elsevier Science
Publication: July 14, 2015
Imprint: Academic Press
Language: English

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug.  By incorporating all of this information into one book, Nonclinical Assessment of Abuse Potential for New Pharmaceuticals is your single resource for everything you need to know to understand and implement the assessment of abuse liability.

  • Provides a consolidated overview of the complex regulatory landscape
  • Offers best practice methodology for conducting animal studies, including selection of doses and positive control agents that will help you improve your own abuse potential studies
  • Includes real-life examples to illustrate how nonclinical data fit into the submission strategy
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug.  By incorporating all of this information into one book, Nonclinical Assessment of Abuse Potential for New Pharmaceuticals is your single resource for everything you need to know to understand and implement the assessment of abuse liability.

More books from Elsevier Science

Cover of the book Singularity and Dynamics on Discontinuous Vector Fields by
Cover of the book Encyclopedia of Insects by
Cover of the book Data Assimilation for the Geosciences by
Cover of the book Ethical Behaviour in the E-Classroom by
Cover of the book Managing Your Library and its Quality by
Cover of the book Recent Progress in Functional Analysis by
Cover of the book An Efficient Energy Future by
Cover of the book Personnel Protection: Threat Assessment Profile by
Cover of the book Gas and Oil Reliability Engineering by
Cover of the book Telecommunications Demystified by
Cover of the book The Science of Grapevines by
Cover of the book Advances in the Study of Behavior by
Cover of the book Basic Neurochemistry by
Cover of the book Drugs During Pregnancy and Lactation by
Cover of the book Introduction to Probability Models by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy